FDA to require mammogram reports include breast density information

FDA to require mammogram reports include breast density information

Mammograms remain the best screening tool for the early diagnosis of breast cancer, yet dense breasts — that occur in 50% of women who get mammograms — make breast cancer harder to detect. National Cancer Center salutes the FDA’s new breast density notification requirement for mammogram centers, which will provide for more thorough and potentially accurate diagnosis.

To read full article click here.